| |
| |
|
| Insider
Information: |
Dunbar Geoffrey C |
| Relationship: |
SVP, Clin. Dev. & Reg.... |
| City: |
Winston-Salem |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,153 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$590 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,153 |
|
|
| Total
Value |
$590 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
SVP, Clin. Dev. & Reg.... |
2010-12-20 |
1,153 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-20 |
4 |
S |
$26.02 |
$231,120 |
D/D |
(8,882) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-20 |
4 |
OE |
$1.75 |
$15,544 |
D/D |
8,882 |
10,035 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-17 |
4 |
S |
$26.08 |
$54,765 |
D/D |
(2,100) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-17 |
4 |
OE |
$1.75 |
$3,675 |
D/D |
2,100 |
3,253 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-16 |
4 |
S |
$25.15 |
$5,030 |
D/D |
(200) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-16 |
4 |
OE |
$1.75 |
$350 |
D/D |
200 |
1,353 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-08 |
4 |
S |
$22.68 |
$255,150 |
D/D |
(11,250) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-12-08 |
4 |
OE |
$5.10 |
$57,375 |
D/D |
11,250 |
12,403 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-11-05 |
4 |
OE |
$1.75 |
$1,225 |
D/D |
700 |
1,853 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-11-05 |
4 |
S |
$25.02 |
$17,512 |
D/D |
(700) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-11-04 |
4 |
S |
$25.07 |
$195,139 |
D/D |
(7,784) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-11-04 |
4 |
OE |
$1.75 |
$13,622 |
D/D |
7,784 |
8,937 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-11-03 |
4 |
S |
$25.05 |
$24,699 |
D/D |
(986) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-11-03 |
4 |
OE |
$1.75 |
$1,726 |
D/D |
986 |
2,139 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-05-13 |
4 |
OE |
$1.75 |
$2,615 |
D/D |
1,494 |
2,647 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-05-13 |
4 |
S |
$25.00 |
$37,350 |
D/D |
(1,494) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-04-28 |
4 |
S |
$24.00 |
$352,800 |
D/D |
(14,700) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-04-28 |
4 |
OE |
$1.75 |
$25,725 |
D/D |
14,700 |
15,853 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-04-27 |
4 |
S |
$24.00 |
$4,800 |
D/D |
(200) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-04-27 |
4 |
OE |
$1.75 |
$350 |
D/D |
200 |
1,353 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-04-26 |
4 |
S |
$24.00 |
$6,168 |
D/D |
(257) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
SVP, Clin. Dev. & Reg. Affairs |
• – – |
2010-04-26 |
4 |
OE |
$1.75 |
$450 |
D/D |
257 |
1,410 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Clin. Dev. & Reg. Affairs |
• – – |
2009-12-16 |
4 |
S |
$21.86 |
$494,170 |
D/D |
(22,602) |
1,153 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Clin. Dev. & Reg. Affairs |
• – – |
2009-09-18 |
4 |
S |
$17.19 |
$189,101 |
D/D |
(11,000) |
23,755 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
VP, Clin. Dev. & Reg. Affairs |
• – – |
2009-09-18 |
4 |
OE |
$1.75 |
$19,250 |
D/D |
11,000 |
34,755 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
